Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 25 peer-reviewed journal articles Updated
Rheumatology

Can You Have FMF If Your Genetic Test Is Negative?

At a Glance

Yes, you can still have Familial Mediterranean Fever (FMF) even if your genetic test is negative. FMF is primarily a clinical diagnosis based on your symptom history, attack patterns, and response to colchicine. Genetic tests can miss rare variants or only show a single mutation.

In this answer

4 sections

01

The Limitations of Genetic Testing

02

Clinical Diagnostic Criteria

03

Treatment Without Genetic Confirmation

04

Exploring Other Possibilities and Next Steps

Yes, you can still have Familial Mediterranean Fever (FMF) even if your genetic test is completely negative or only shows a single mutation. FMF is primarily a clinical diagnosis, meaning doctors rely heavily on your history of symptoms, laboratory tests during active attacks, and how well you respond to treatment to make a final determination [1][2].

While genetic testing can confirm FMF, “diagnostic limbo” is common because the tests have important limitations. You should not be discouraged if your test results do not immediately match your lived experience.

The Limitations of Genetic Testing

FMF is linked to mutations in the MEFV gene. A classic genetic diagnosis requires identifying two mutations (one inherited from each parent). However, genetic testing is not perfect:

  • Limited Panels: Many standard genetic tests only look for the most common MEFV mutations (such as M694V). If you have a rare variant, standard testing may miss it entirely [3].
  • Single Mutations: Many patients present with typical FMF symptoms but only have one detectable mutation (known as being heterozygous) [4][5].
  • Unknown Genes: Some patients with classic FMF symptoms lack any identifiable MEFV mutations whatsoever [6][7].

Because of these gaps, a negative or inconclusive genetic test does not rule out the disease. The genetic results must be interpreted cautiously and always within the context of your actual symptoms [8][9].

Clinical Diagnostic Criteria

When genetic testing is incomplete or negative, specialists rely on validated clinical frameworks, such as the Tel-Hashomer criteria or the Eurofever/PRINTO criteria, to diagnose FMF [1][10]. These criteria evaluate specific patterns in your health history:

  • Attack Patterns: Recurrent, short episodes of fever that typically last 1 to 3 days [11].
  • Localized Inflammation: Painful inflammation in the lining of the abdomen (peritonitis), the lungs (pleuritis), or single joints (monoarthritis) during an attack [11][12].
  • Blood Markers: Evidence of elevated inflammatory markers in your blood—such as C-Reactive Protein (CRP) or Erythrocyte Sedimentation Rate (ESR)—during an active episode [13].

These diagnostic tools are highly sensitive and provide a valid, accepted way to diagnose FMF and differentiate it from other conditions, even without complete genetic proof [1][14].

Treatment Without Genetic Confirmation

If you meet the clinical criteria for FMF, a formal diagnosis is considered valid and sufficient for treatment. Your doctor will likely recommend a trial of colchicine, which is the standard of care for preventing FMF attacks [15].

A positive response to colchicine—meaning a significant reduction in the frequency and severity of your attacks—strongly supports the diagnosis, even if your genetics are unclear [16][15]. Because uncontrolled inflammation can lead to severe long-term complications like AA amyloidosis (a condition where abnormal proteins build up and can cause severe kidney damage) [17][18], patients who meet the clinical criteria are routinely prescribed colchicine to protect their health, regardless of their genetic test results [19][20].

What to expect during a colchicine trial: Doctors generally evaluate the trial over a period of at least 6 months to see if your attack frequency decreases [20]. Common gastrointestinal side effects, such as diarrhea or nausea, can occur when starting colchicine [21]. Let your doctor know if you experience these, as they may suggest adjusting or splitting your dose to help manage them [22].

Exploring Other Possibilities and Next Steps

If you have FMF-like symptoms but lack genetic confirmation, it is also important to consider other autoinflammatory diseases. Conditions such as TRAPS, PFAPA syndrome, or HIDS/MKD can sometimes cause periodic fevers that mimic FMF [23][24]. Doctors differentiate these by looking at specific clues:

  • TRAPS fevers typically last much longer than FMF (often 1 to 3 weeks) [24].
  • PFAPA is characterized by highly regular fevers accompanied by mouth sores and a sore throat [25].
  • HIDS/MKD often starts in early childhood and features swollen lymph nodes alongside stomach pain and diarrhea [23].

Because diagnostic criteria can be complex, you may want to ask your primary care provider for a referral to a rheumatologist or an autoinflammatory disease specialist. They will have the specialized expertise needed to correctly interpret your symptoms alongside your genetic results and guide your treatment plan.

Common questions in this guide

Can you be diagnosed with FMF if your genetic test is negative?
Yes, Familial Mediterranean Fever is primarily a clinical diagnosis. Doctors rely heavily on your history of symptoms, the length of your attacks, and blood test results during flare-ups to make a diagnosis, even if standard genetic tests find no mutations.
Why might my FMF genetic test come back negative?
Standard genetic panels often only look for the most common MEFV gene mutations. You may have a rare variant that the test missed, or you might only have one detectable mutation despite having classic FMF symptoms.
What is a colchicine trial for FMF?
A colchicine trial involves taking the standard FMF medication for at least 6 months to see if your attack frequency decreases. A positive response strongly supports an FMF diagnosis and helps prevent long-term complications, regardless of your genetic test results.
What criteria do doctors use to clinically diagnose FMF?
Specialists often use the Tel-Hashomer or Eurofever/PRINTO criteria. These evaluate your history of recurrent short fevers, painful inflammation in the abdomen or lungs, and elevated inflammatory markers in your blood during an active episode.
What other conditions cause recurrent fevers similar to FMF?
Other autoinflammatory conditions like TRAPS, PFAPA syndrome, and HIDS/MKD can cause periodic fevers that mimic FMF. A rheumatologist will look at the length of your fevers and other specific symptoms, like mouth sores, to tell them apart.

Questions for Your Doctor

6 questions

  • •Was my genetic test a limited panel of common mutations, or did it fully sequence the MEFV gene?
  • •Based on my symptom history, do I meet the clinical criteria (like the Tel-Hashomer criteria) for an FMF diagnosis?
  • •Would I be a candidate for a trial of colchicine to see if my symptoms improve?
  • •How long would a colchicine trial last, and what should I do if I experience stomach side effects like diarrhea?
  • •What specific inflammatory markers (like CRP or ESR) should we test during my next attack to help confirm the diagnosis?
  • •Should we explore other autoinflammatory conditions like TRAPS or PFAPA, or should I be referred to a rheumatologist?

Questions for You

4 questions

  • •What specific symptoms occur during my episodes (e.g., localized abdominal pain, chest pain, joint swelling), and exactly how many days do they typically last?
  • •Have I had blood tests drawn at the peak of an active attack to measure inflammation?
  • •Have any blood relatives been diagnosed with FMF or experienced similar unexplained recurrent fevers?
  • •Do my attacks happen randomly, or do they follow a highly predictable schedule with other symptoms like mouth sores?

Related questions

Can You Eat Grapefruit While Taking Colchicine for FMF?What Triggers Familial Mediterranean Fever Attacks?FMF Attack vs Appendicitis: How to Tell the DifferenceHow Did I Get FMF? Inheritance & Carriers ExplainedHow to Manage Colchicine Stomach Upset & DiarrheaHow do you treat an active FMF attack?Why Do IL-1 Inhibitors Work When Colchicine Fails?Is Colchicine Safe During Pregnancy for FMF?Is Familial Mediterranean Fever an Autoimmune Disease?Does the M694V Mutation Make FMF Symptoms More Severe?What is Protracted Febrile Myalgia Syndrome (PFMS)?Why Is the SAA Blood Test Important for FMF Patients?What Are the Signs of AA Amyloidosis in FMF?Can You Stop Colchicine Treatment for FMF?

References

References (25)
  1. 1

    Differentiating children with familial Mediterranean fever from other recurrent fever syndromes: The utility of new Eurofever/PRINTO classification criteria.

    Kışla Ekinci RM, Balcı S, Erol AH, et al.

    Archives of rheumatology 2021; (36(4)):493-498 doi:10.46497/ArchRheumatol.2021.8616.

    PMID: 35382375
  2. 2

    Comparison of diagnostic criteria for children with familial Mediterranean fever.

    Akyol Onder EN, Ozcan KE, Sahin FI, et al.

    European journal of pediatrics 2022; (181(4)):1661-1667 doi:10.1007/s00431-021-04370-y.

    PMID: 35006379
  3. 3

    Other autoinflammatory disease genes in an FMF-prevalent population: a homozygous MVK mutation and a novel heterozygous TNFRSF1A mutation in two different Turkish families with clinical FMF.

    Karacan İ, Uğurlu S, Tolun A, et al.

    Clinical and experimental rheumatology 2017; (35 Suppl 108(6)):75-81.

    PMID: 29148404
  4. 4

    Typical Familial Mediterranean Fever associated with the heterozygous missense sequence p.T577N variant of the MEFV gene: Report on two Northern European Caucasians relatives in France.

    Elhani I, Dumont A, Deshayes S, et al.

    Joint bone spine 2020; (87(3)):251-255 doi:10.1016/j.jbspin.2020.01.005.

    PMID: 32007646
  5. 5

    Characteristics and outcomes of adult patients with familial Mediterranean fever: Comparison of patients with one versus two pathogenic exon 10 MEFV mutations.

    Dumont A, Vergneault H, Ardois S, et al.

    Joint bone spine 2025; (92(4)):105850 doi:10.1016/j.jbspin.2025.105850.

    PMID: 39892590
  6. 6

    The MEFV gene pathogenic variants and phenotype-genotype correlation in children with familial Mediterranean fever in the Çanakkale population.

    Battal F, Silan F, Topaloğlu N, et al.

    Balkan journal of medical genetics : BJMG 2016; (19(2)):23-28 doi:10.1515/bjmg-2016-0032.

    PMID: 28289585
  7. 7

    Familial Mediterranean fever gene mutations in north-eastern part of Anatolia with special respect to rare mutations.

    Dogan H, Faruk Bayrak O, Emet M, et al.

    Gene 2015; (568(2)):170-5.

    PMID: 26003477
  8. 8

    Involvement of Mediterranean fever gene mutations in colchicine-responsive enterocolitis: a retrospective cohort study.

    Nakase H, Wagatsuma K, Kobayashi T, et al.

    EBioMedicine 2024; (110()):105454 doi:10.1016/j.ebiom.2024.105454.

    PMID: 39566399
  9. 9

    Vitamin D binding protein genotype frequency in familial Mediterranean fever patients.

    Orhan C, Seyhan B, Baykara O, et al.

    Scandinavian journal of rheumatology 2020; (49(6)):484-488 doi:10.1080/03009742.2020.1762922.

    PMID: 32940108
  10. 10

    Familial Mediterranean Fever Is Important in the Differential Diagnosis of Recurrent Aseptic Meningitis in Japan.

    Hosoi T, Ishii K, Tozaka N, et al.

    Internal medicine (Tokyo, Japan) 2020; (59(1)):125-128 doi:10.2169/internalmedicine.3432-19.

    PMID: 31511485
  11. 11

    Is the performance of the international severity scoring system for familial mediterranean fever in children better than other scoring systems?

    Ozcan G, Cayci S, Celikel Acar B, et al.

    International journal of clinical practice 2021; (75(11)):e14678 doi:10.1111/ijcp.14678.

    PMID: 34328662
  12. 12

    Disease severity and genotype-phenotype correlation in adult patients with familial Mediterranean fever.

    Tuncer Kuru F, Gokcen N, Yazici A, Cefle A

    Modern rheumatology 2023; (34(1)):214-219 doi:10.1093/mr/road007.

    PMID: 36688581
  13. 13

    Treatment of familial Mediterranean fever with anakinra in patients unresponsive to colchicine.

    Pecher AC, Igney-Oertel A, Kanz L, Henes J

    Scandinavian journal of rheumatology 2017; (46(5)):407-409 doi:10.1080/03009742.2016.1245780.

    PMID: 28097903
  14. 14

    Performance of Tel-Hashomer, Livneh, pediatric and new Eurofever/PRINTO classification criteria for familial Mediterranean fever in a referral center.

    Tanatar A, Sönmez HE, Karadağ ŞG, et al.

    Rheumatology international 2020; (40(1)):21-27 doi:10.1007/s00296-019-04463-w.

    PMID: 31646357
  15. 15

    An adult case of atypical familial Mediterranean fever (pyrin-associated autoinflammatory disease) similar to adult-onset Still's disease.

    Tsuruma H, Sato H, Hasegawa E, et al.

    Clinical case reports 2019; (7(4)):801-805 doi:10.1002/ccr3.2102.

    PMID: 30997089
  16. 16

    Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes.

    De Benedetti F, Gattorno M, Anton J, et al.

    The New England journal of medicine 2018; (378(20)):1908-1919 doi:10.1056/NEJMoa1706314.

    PMID: 29768139
  17. 17

    Infections and AA amyloidosis: An overview.

    Deshayes S, Aouba A, Grateau G, Georgin-Lavialle S

    International journal of clinical practice 2021; (75(6)):e13966 doi:10.1111/ijcp.13966.

    PMID: 33368925
  18. 18

    Clinicopathological Spectrum of Renal Amyloidosis in Young.

    Garg N, Jain S, Chauhan S, et al.

    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 2020; (31(5)):1085-1090 doi:10.4103/1319-2442.301175.

    PMID: 33229773
  19. 19

    A patient with familial Mediterranean fever mimicking diarrhea-dominant irritable bowel syndrome who successfully responded to treatment with colchicine: a case report.

    Kumei S, Ishioh M, Murakami Y, et al.

    Journal of medical case reports 2022; (16(1)):247 doi:10.1186/s13256-022-03446-z.

    PMID: 35739566
  20. 20

    French protocol for the diagnosis and management of familial Mediterranean fever.

    Georgin-Lavialle S, Savey L, Cuisset L, et al.

    La Revue de medecine interne 2023; (44(11)):602-616 doi:10.1016/j.revmed.2023.10.441.

    PMID: 37903671
  21. 21

    Efficacy and safety of colchicine for atrial fibrillation prevention: An updated meta-analysis of randomized controlled trials.

    Tian X, Zhang N, Korantzopoulos P, et al.

    International journal of cardiology 2024; (406()):132068 doi:10.1016/j.ijcard.2024.132068.

    PMID: 38648916
  22. 22

    Colchicine for the secondary prevention of cardiovascular events.

    Ebrahimi F, Ebrahimi R, Beer M, et al.

    The Cochrane database of systematic reviews 2025; (11()):CD014808 doi:10.1002/14651858.CD014808.pub2.

    PMID: 41224205
  23. 23

    Current Therapeutic Options for the Main Monogenic Autoinflammatory Diseases and PFAPA Syndrome: Evidence-Based Approach and Proposal of a Practical Guide.

    Soriano A, Soriano M, Espinosa G, et al.

    Frontiers in immunology 2020; (11()):865 doi:10.3389/fimmu.2020.00865.

    PMID: 32655539
  24. 24

    Autoinflammatory Diseases with Periodic Fevers.

    Sag E, Bilginer Y, Ozen S

    Current rheumatology reports 2017; (19(7)):41 doi:10.1007/s11926-017-0670-8.

    PMID: 28631068
  25. 25

    Colchicine - From rheumatology to the new kid on the block: Coronary syndromes and COVID-19.

    Surma S, Basiak M, Romańczyk M, et al.

    Cardiology journal 2023; (30(2)):297-311 doi:10.5603/CJ.a2021.0123.

    PMID: 34642922

This page explains the clinical diagnosis of Familial Mediterranean Fever for educational purposes only. Always consult a rheumatologist or healthcare provider for an accurate evaluation of your specific symptoms and genetic test results.

Get notified when new evidence is published on Familial Mediterranean fever.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.